BamSEC and AlphaSense Join Forces
Learn More

Enumeral Biomedical Holdings, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 3 pages Amendment No. 1 to Intellectual Property Security Agreement
12/34/56
EX-10.8
from 10-Q 3 pages Amendment No. 2 to Study Agreement Between Merck Sharp & Dohme Corp. and Enumeral Biomedical Holdings Inc
12/34/56
EX-10.7
from 10-Q 16 pages Enumeral Biomedical Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.6
from 10-Q 16 pages Enumeral Biomedical Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.5
from 10-Q 13 pages Intellectual Property Security Agreement
12/34/56
EX-10.4
from 10-Q 26 pages Registration Rights Agreement
12/34/56
EX-10.3
from 10-Q 14 pages Escrow Agreement
12/34/56
EX-10.2
from 10-Q 43 pages Subscription Agreement
12/34/56
EX-10.1
from 10-Q 29 pages May 12, 2017 Mr. Wael Fayad Chairman, President and Chief Executive Officer Enumeral Biomedical Holdings, Inc. 200 Cambridgepark Drive Suite 2000 Cambridge, Ma 02140 Re: Enumeral Biomedical Holdings, Inc. Dear Mr. Fayad
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Letter Agreement
12/34/56
EX-10.42
from 10-K 14 pages Enumeral Biomedical Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.7
from 10-K 3 pages Amendment No. 1 to Definitive License and Transfer Agreement
12/34/56
EX-10.41
from S-1 14 pages Enumeral Biomedical Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.40
from S-1 13 pages Enumeral Biomedical Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.39
from S-1 17 pages Enumeral Biomedical Holdings, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.2
from 8-K 2 pages Amendment to Amended and Restated Warrants to Purchase Stock
12/34/56
EX-10.11
from 10-Q 6 pages Material contract
12/34/56
EX-10.10
from 10-Q 5 pages Enumeral Biomedical Holdings, Inc. Non-Qualified Stock Option Agreement
12/34/56
EX-10.9
from 10-Q 4 pages Enumeral Biomedical Holdings, Inc. 2014 Equity Incentive Plan Incentive Stock Option Agreement
12/34/56
EX-10.8
from 10-Q 21 pages Confidential Portions of This Document Have Been Redacted and Omitted Pursuant to a Request for Confidential Treatment Filed With the Securities and Exchange Commission (The "SEC") Pursuant to Rule 24b-2 Under the Securities Exchange Act of 1934, as Amended. the Redacted and Omitted Portions Are Indicated With the Notation “*” and Have Been Filed Separately With the SEC. Confidential September 21, 2016
12/34/56